| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |